Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06819202

Effect of Hyperbaric Oxygen Therapy(HBOT) on Patients With Sudden Sensorineural Hearing Loss(SSNHL) and Coagulation Function

Effect of Hyperbaric Oxygen Therapy on Patients With Sudden Sensorineural Hearing Loss and Coagulation Function

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
1,309 (estimated)
Sponsor
Sun Yuting · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The objective of this observational study was to understand the effect of HBO on patients with SSNHL and its association with coagulation function and prognosis. The main question it aims to answer is whether HBO therapy can improve outcomes and coagulation function in patients with SSNHL. The prognosis of SSNHL patients receiving HBO and SSNHL patients not receiving HBO were compared

Conditions

Interventions

TypeNameDescription
OTHERHyperbaric oxygen treatmentHBO therapy is the process of inhaling 100% pure oxygen in an environment above one atmosphere (pressure range: 2.0-3.0 absolute atmospheres) to treat a disease.

Timeline

Start date
2025-06-01
Primary completion
2025-06-01
Completion
2025-12-01
First posted
2025-02-11
Last updated
2025-05-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06819202. Inclusion in this directory is not an endorsement.